![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
FF Moebius, GG Burrows, J Striessnig and H Glossmann
Institut fur Biochemische Pharmakologie, Universitat Innsbruck, Austria.
The phenylalkylamine emopamil prevents brain damage due to experimental cerebral ischemia. Stereoselective, high affinity, binding sites for (- )-[3H]emopamil in guinea pig brain cortex and liver membranes have been proposed to mediate its antiischemic effect. Using [N-methyl-3H]LU49888 as a photoaffinity probe we now provide evidence that the cation- sensitive emopamil binding site is localized on a 22-kDa polypeptide in guinea pig liver, kidney, lung, and adrenal gland. This 22-kDa polypeptide binds other antiischemic drugs with high affinity and is a nonglycosylated integral membrane protein of the endoplasmic reticulum. It can be solubilized with digitonin without changes in its drug- binding properties. The solubilized binding activity has a sedimentation coefficient of 12.0 +/- 0.4 S and an apparent Stokes radius of 6.0 +/- 0.1 nm. From these data it is concluded that the 22- kDa polypeptide is associated in a larger oligomeric complex with a molecular mass of at least 84 kDa. [N-methyl-3H]LU49888 also specifically labels a second 27-kDa polypeptide in the endoplasmic reticulum, which can be distinguished from the 22-kDa polypeptide by its pharmacological and hydrodynamic properties. The photolabeled 22- kDa polypeptide was partially purified under denaturating conditions. This will allow the further structural analysis of this putative target for antiischemic drugs.
This article has been cited by other articles:
|
|
 |
|
  A. Gioti, J. M. Pradier, E. Fournier, P. Le Pecheur, C. Giraud, D. Debieu, J. Bach, P. Leroux, and C. Levis A Botrytis cinerea Emopamil Binding Domain Protein, Required for Full Virulence, Belongs to a Eukaryotic Superfamily Which Has Expanded in Euascomycetes Eukaryot. Cell, February 1, 2008; 7(2): 368 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. G. Huber, E. Wappl-Kornherr, M. J. Sinnegger-Brauns, J.-C. Hoda, D. Walter-Bastl, and J. Striessnig Opposite Effects of a Single IIIS5 Mutation on Phenylalkylamine and Dihydropyridine Interaction with L-type Ca2+ Channels J. Biol. Chem., December 31, 2004; 279(53): 55211 - 55217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. F. Moebius, R. J. Reiter, K. Bermoser, H. Glossmann, S. Y. Cho, and Y.-K. Paik Pharmacological Analysis of Sterol Delta 8-Delta 7 Isomerase Proteins with [3H]Ifenprodil Mol. Pharmacol., September 1, 1998; 54(3): 591 - 598. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. F. Moebius, B. U. Fitzky, J. N. Lee, Y.-K. Paik, and H. Glossmann Molecular cloning and expression of the human Delta 7-sterol reductase PNAS, February 17, 1998; 95(4): 1899 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Silve, P. H. Dupuy, C. Labit-Lebouteiller, M. Kaghad, P. Chalon, A. Rahier, M. Taton, J. Lupker, D. Shire, and G. Loison Emopamil-binding Protein, a Mammalian Protein That Binds a Series of Structurally Diverse Neuroprotective Agents, Exhibits Delta 8-Delta 7 Sterol Isomerase Activity in Yeast J. Biol. Chem., September 13, 1996; 271(37): 22434 - 22440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hanner, F. F. Moebius, F. Weber, M. Grabner, Jör. Striessnig, and H. Glossmann Phenylalkylamine Ca[IMAGE] Antagonist Binding Protein J. Biol. Chem., March 31, 1995; 270(13): 7551 - 7557. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
